LANXESS Archives | Market Krystal

LANXESS Introduces Cosmelin Biodegradable Ester Line for Cosmetics Formulators

admin — Mon, 26 Oct 2026 00:00:00 +0000

LANXESS is launching Cosmelin, a new line of readily biodegradable esters for cosmetics and personal care manufacturers making skin and hair care, sun care and decorative cosmetics. The range meets the OECD 301 standard for ready biodegradability and is designed as a functional substitute for cyclomethicone and dimethicone, degrading significantly faster and more completely in the environment after use. The portfolio includes monoester, diester, polyol ester and trimellitate products, including Cosmelin 5131 (Isononyl Isononanoate), Cosmelin 5145 (Cetyl Ethylhexanoate) and Cosmelin 5141 (Triisotridecyl Trimellitate).

Why it matters

Cosmetics formulators gain a readily biodegradable alternative to silicone emollients, which could shift demand from cyclomethicone and dimethicone toward ester-based ingredients in clean beauty products.

Key facts

Companies	LANXESS
Chemicals	Cosmelin esters, Isononyl Isononanoate, Cetyl Ethylhexanoate, Triisotridecyl Trimellitate, cyclomethicone, dimethicone
Timing	2026-10-26
End uses	skin care, hair care, sun care, decorative cosmetics, color cosmetics, personal care

Market context

Cosmetic esters are oily emollients that give creams, lotions, sunscreens and makeup a smooth, non-greasy skin feel and help dissolve or disperse active ingredients. Demand is driven mainly by skin care, hair care, sun care and color cosmetics, along with the wider personal care segment, where formulators continually reshape their ingredient lists around sensory performance and regulatory expectations. Silicone emollients such as cyclomethicone and dimethicone have long been the default choice for silky texture, but they persist in the environment, which has pushed brand owners and ingredient suppliers toward alternatives that break down more readily after use. Readily biodegradable ester chemistries can serve as functional replacements in many formulations, so a credible option of this type can shift specification decisions and gradually redirect volume from silicones. For ester producers and silicone suppliers alike, such moves tend to reshape competitive positioning more than overall market size.

Source: official release on lanxess.com. Summary and context written by Market Krystal.

The post LANXESS Introduces Cosmelin Biodegradable Ester Line for Cosmetics Formulators appeared first on Market Krystal.

LANXESS to unveil new Rely+On Medero disinfectant at Medica trade fair

admin — Thu, 22 Oct 2026 00:00:00 +0000

LANXESS will launch its new broad-spectrum disinfectant Rely+On Medero at Medica 2026, taking place November 16–19 in Düsseldorf, where it will also showcase its Rely+On infection-prevention portfolio and active ingredients for disinfectant formulation. The product is based on Potassium Monopersulfate (Oxone) and in-situ generated active chlorine, is approved as a medical-device disinfectant under EU Class IIa, and is authorised as Product Type II under the Biocidal Products Regulation for non-medical hard surfaces.

Key facts

Companies	LANXESS
Chemicals	Potassium Monopersulfate (Oxone), active chlorine
Location	Messe Düsseldorf, Hall 11, Booth E36
Timing	2026-10-22, November 16–19, 2026
End uses	healthcare sector, medical devices, hard surfaces in medical practices and hospitals, intensive care units, isolation rooms, public sector

Market context

Potassium monopersulfate, sold commercially as Oxone, is a powerful oxidant and a widely used active in surface and instrument disinfectants, bleaching and chemical synthesis. Active chlorine compounds are another established biocidal oxidizer used against bacteria, viruses and spores. Demand for disinfectants of this kind is driven mainly by healthcare, where hospitals, intensive care units, isolation rooms and medical device reprocessing require validated hard-surface and instrument cleaning. Public sector facilities and institutional cleaning contractors form a second demand pool. Regulatory approval is central to commercial access: medical-device disinfectants are classed under EU medical device rules, while non-medical surface products fall under the Biocidal Products Regulation with product-type authorisations. Suppliers of active ingredients and formulated products compete on efficacy, material compatibility, approvals and supply reliability, and infection-control trade fairs are a common venue for launching such products.

Source: official release on lanxess.com. Summary and context written by Market Krystal.

The post LANXESS to unveil new Rely+On Medero disinfectant at Medica trade fair appeared first on Market Krystal.

LANXESS launches Rely+On Medero powder disinfectant for medical sector

admin — Tue, 20 Oct 2026 00:00:00 +0000

LANXESS is launching Rely+On Medero, a powder disinfectant for medical devices and surfaces based on potassium monopersulfate (Oxone) and in-situ generated active chlorine. The product is approved as a Class IIa medical device disinfectant under the EU Medical Device Regulation and is offered in 20- or 40-gram sachets and in 1 kilo or 5 kilo units. LANXESS aims to start distribution in many countries across Europe, Asia and South America.

Key facts

Companies	LANXESS
Chemicals	Potassium monopersulfate (Oxone), active chlorine
Timing	October 20, 2026
End uses	medical devices and surfaces in medical practices and hospitals, including wards, intensive care units, operating theatres and isolation rooms

Market context

Potassium monopersulfate, sold commercially as Oxone, is a triple-salt oxidant used in water treatment, pulp and paper bleaching, surface cleaning, and as a reagent in organic synthesis. Its ability to release active oxygen makes it useful where chlorine-based chemistry is less suitable. Demand for disinfectants of this kind is driven mainly by hospitals, clinics, and other healthcare facilities, where infection control rules require validated products for medical devices and surfaces. Regulatory classification matters greatly in this segment: products sold as medical device disinfectants must meet specific conformity requirements, which limits competition to suppliers able to meet them. Powder formats in small sachets can simplify storage and transport compared with ready-to-use liquids, and they allow dosing at the point of use. Any move by a major specialty chemicals producer into this niche tends to affect distributors and smaller disinfectant formulators competing for hospital contracts, and it can shift buyer attention toward suppliers with established regulatory approvals.

Source: official release on lanxess.com. Summary and context written by Market Krystal.

The post LANXESS launches Rely+On Medero powder disinfectant for medical sector appeared first on Market Krystal.